INDSWFTLAB

Ind-Swift Laboratories Share Price

 

 

Start SIP in INDSWFTLAB

Start SIP

Performance

  • Low
  • ₹131
  • High
  • ₹136
  • 52 Week Low
  • ₹69
  • 52 Week High
  • ₹143
  • Open Price₹134
  • Previous Close₹137
  • Volume406,512
  • 50 DMA₹107.51
  • 100 DMA₹103.55
  • 200 DMA₹102.13

Investment Returns

  • Over 1 Month + 47.25%
  • Over 3 Month + 27.69%
  • Over 6 Month + 34.21%
  • Over 1 Year + 35.59%

Smart Investing Starts Here Start SIP with Ind-Swift Laboratories for Steady Growth!

Invest Now

Ind-Swift Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 4.4
  • PEG Ratio
  • 1.2
  • Market Cap Cr
  • 1,086
  • P/B Ratio
  • 0.8
  • Average True Range
  • 7.31
  • EPS
  • 5.8
  • Dividend Yield
  • 0
  • MACD Signal
  • 6.87
  • RSI
  • 71.04
  • MFI
  • 94.78

Ind-Swift Laboratories Financials

Ind-Swift Laboratories Technicals

EMA & SMA

Current Price
₹133.07
-4.08 (-2.97%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹117.26
  • 50 Day
  • ₹107.51
  • 100 Day
  • ₹103.55
  • 200 Day
  • ₹102.13

Resistance and Support

133.6 Pivot Speed
  • R3 141.01
  • R2 138.72
  • R1 135.89
  • S1 130.77
  • S2 128.48
  • S3 125.65

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ind-Swift Labs. (Nse) has an operating revenue of Rs. 594.47 Cr. on a trailing 12-month basis. An annual revenue de-growth of -52% needs improvement, Pre-tax margin of 46% is great, ROE of 21% is exceptional. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 35% and 38% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 21% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 98 which is a GREAT score indicating consistency in earnings, a RS Rating of 92 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 74 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ind-Swift Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-31 Quarterly Results
2025-11-14 Quarterly Results
2025-08-13 Quarterly Results
2025-08-11 Audited Results
2025-05-30 Audited Results

Ind-Swift Laboratories F&O

Ind-Swift Laboratories Shareholding Pattern

39.5%
0%
14.33%
0%
35.07%
11.1%

About Ind-Swift Laboratories

  • NSE Symbol
  • INDSWFTLAB
  • BSE Symbol
  • 532305
  • Chairman & Managing Director
  • Mr. Navrattan Munjal
  • ISIN
  • INE915B01019

Similar Stocks to Ind-Swift Laboratories

Ind-Swift Laboratories FAQs

Ind-Swift Laboratories share price is ₹133 As on 12 February, 2026 | 02:12

The Market Cap of Ind-Swift Laboratories is ₹1086 Cr As on 12 February, 2026 | 02:12

The P/E ratio of Ind-Swift Laboratories is 4.4 As on 12 February, 2026 | 02:12

The PB ratio of Ind-Swift Laboratories is 0.8 As on 12 February, 2026 | 02:12

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23